Bogert Nicolai V, Werner Isabella, Kornberger Angela, Meybohm Patrick, Moritz Anton, Keller Till, Stock Ulrich A, Beiras-Fernandez Andres
Department of Thoracic and Cardiovascular Surgery, University Hospital Frankfurt, Goethe University, Frankfurt/Main, Germany.
Department of Anaesthesiology, University Hospital Frankfurt, Goethe University, Frankfurt/Main, Germany.
Sci Rep. 2016 Feb 25;6:21996. doi: 10.1038/srep21996.
Patients with risks of ischemic injury, e.g. during circulatory arrest in cardiac surgery, or after resuscitation are subjected to therapeutic hypothermia. For aortic surgery, the body is traditionally cooled down to 18 °C and then rewarmed to body temperature. The role of hypothermia and the subsequent rewarming process on leukocyte-endothelial interactions and expression of junctional-adhesion-molecules is not clarified yet. Thus, we investigated in an in-vitro model the influence of temperature modulation during activation and transendothelial migration of leukocytes through human endothelial cells. Additionally, we investigated the expression of JAMs in the rewarming phase. Exposure to low temperatures alone during transmigration scarcely affects leukocyte extravasation, whereas hypothermia during treatment and transendothelial migration improves leukocyte-endothelial interactions. Rewarming causes a significant up-regulation of transmigration with falling temperatures. JAM-A is significantly modulated during rewarming. Our data suggest that transendothelial migration of leukocytes is not only modulated by cell-activation itself. Activation temperatures and the rewarming process are essential. Continued hypothermia significantly inhibits transendothelial migration, whereas the rewarming process enhances transmigration strongly. The expression of JAMs, especially JAM-A, is strongly modulated during the rewarming process. Endothelial protection prior to warm reperfusion and mild hypothermic conditions reducing the difference between hypothermia and rewarming temperatures should be considered.
有缺血性损伤风险的患者,例如在心脏手术循环骤停期间或复苏后,会接受治疗性低温治疗。对于主动脉手术,传统上是将身体冷却至18°C,然后再复温至体温。低温及随后的复温过程对白细胞与内皮细胞相互作用及连接粘附分子表达的作用尚不清楚。因此,我们在体外模型中研究了白细胞通过人内皮细胞激活和跨内皮迁移过程中温度调节的影响。此外,我们还研究了复温阶段连接粘附分子(JAMs)的表达。迁移过程中仅暴露于低温几乎不影响白细胞渗出,而治疗和跨内皮迁移期间的低温可改善白细胞与内皮细胞的相互作用。随着温度下降,复温会导致迁移显著上调。复温期间JAM-A受到显著调节。我们的数据表明,白细胞的跨内皮迁移不仅受细胞激活本身的调节。激活温度和复温过程至关重要。持续低温显著抑制跨内皮迁移,而复温过程则强烈增强迁移。JAMs的表达,尤其是JAM-A,在复温过程中受到强烈调节。应考虑在温暖再灌注前进行内皮保护以及采用轻度低温条件以减小低温与复温温度之间的差异。